Discover the latest Biomedical Imaging and Metabolomics equipment at NANBIOSIS platforms

Seminar on imaging and metabolomics platforms at UV, featuring NANBIOSIS equipment and recent biomedical research applications.

Valencia, June 2025 — Researchers and clinicians interested in cutting-edge preclinical imaging and metabolomics technologies are invited to attend the upcoming seminar “Biomedical and Metabolomic Imaging Section: Equipment and Applications”, taking place on Friday, June 27, 2025, at 13:00, in Seminar Room D, Faculty of Medicine and Dentistry, Universitat de València.

The seminar will be delivered by Mustafa Ezzeddin Ayoub (“Musta”), technical expert from the Biomedical and Metabolomic Imaging Section at the University Clinical Hospital of Valencia (UCIM). The session will provide a comprehensive overview of the high-performance imaging and metabolomics equipment available at the facility, with special emphasis on NANBIOSIS Unit 26 – NMR Biomedical Applications II.

Key imaging technologies featured:

• MRI 3 Tesla (MR Solutions) – Advanced preclinical magnetic resonance imaging system for high-resolution in vivo studies.
• PET/CT Scanner – Hybrid positron emission tomography and computed tomography system used in translational research for cancer, neuroscience, and cardiovascular diseases.
• IVIS Imaging System – Optical imaging for bioluminescence and fluorescence in small animal models.
• Irradiator – Preclinical tool for targeted radiobiology experiments.

Metabolomics platform featured:

• 600 MHz Vertical NMR Spectrometer – Essential for metabolomic profiling, biomarker discovery, and metabolic flux analysis in both clinical and preclinical research.

This event will highlight recent equipment upgrades, new research applications, and the scientific capabilities that these platforms bring to biomedical research. Over the past 3-4 years, these instruments have supported a wide range of in vivo and ex vivo applications, contributing to numerous scientific projects in collaboration with academia and the private industry.

Although the seminar is in-person only, the presentation materials will be made available online (in this same webpage) for those interested in learning more about the imaging and metabolomics capabilities supported by NANBIOSIS.

And if you want to collaborate with us, do not forget that our Open Call is due on June 30! You can find more information here.

What is NANBIOSIS?

The goal of NANBIOSIS is to provide comprehensive and integrated advanced solutions for companies and research institutions in biomedical applications. All of this is done through a single-entry point, involving the design and production of biomaterials, nanomaterials, and their nanoconjugates. This includes their characterization from physical-chemical, functional, toxicological, and biological perspectives (preclinical validation).

Leading scientists

The main value of NANBIOSIS is our highly qualified and experienced academic scientists, working in public institutions, renowned universities and other research institutes.

Custom solutions

Designed for either scientific collaboration or the private industry, we adapt our services to your needs, filling the gaps and paving the way towards the next breakthrough.

Cutting-Edge facilities

Publicly funded, with the most advanced equipment, offering a wide variety of services from synthesis of nanoparticles and medical devices, including up to preclinical trials.

Standards of quality

Our services have standards of quality required in the pharmaceutical, biotech and medtech sectors, from Good Practices to ISO certifications.

In order to access our Cutting-Edge Biomedical Solutions with priority access, enter our Competitive Call here.

NANBIOSIS has worked with pharmaceutical companies of all sizes in the areas of drug delivery, biomaterials and regenerative medicine. Here are a few of them: